26 C
Accra
Monday, November 30, 2020
No menu items!

Covid vaccine: Pfizer says it’s ‘94% effective in over-65 years

Must Read

EC outlines measures to ensure PWDs vote independently

The Electoral Commission (EC) says it has put in measures to ensure that People With Disabilities (PWDs) cast their...

“More progress, more prosperity and more development in my 2nd term – President Akufo-Addo

“The New Patriotic Party has the blueprint for the development of Ghana, the foundation for that development has been...

Kantamanto GCB Bank fire started from storeroom

Preliminary investigations have established that the wildfire that gutted the Liberty House branch of the GCB Bank at Kantamanto,...

The coronavirus vaccine developed by Pfizer and BioNTech appears to protect 94% of adults over 65 years old.

More data released from their ongoing phase three trial suggests it works equally well in people of all ages, races and ethnicities.

The companies say they will now apply for authorisation for emergency use of the jab in the US.

The findings are based on two doses given to more than 41,000 people around the world.

Last week, Pfizer and BioNTech published preliminary data showing the vaccine offered 90% protection against Covid -19 and there were no safety concerns.

This was followed by impressive data on another vaccine, made by US  company Moderna suggesting nearly 95% protection.

Wednesday’s data from Pfizer and BioNTech suggests the vaccine is 95% effective, based on 170 cases of Covid-19 developing in volunteers – just eight were in the group given the vaccine, suggesting it offers good protection.

Although the full trial data has yet to be published, the companies say there have been no serious safety concerns. But they did notice headaches and fatigue in about 2% of volunteers given the vaccine.

In the trial, 42% of all participants are from diverse ethnic backgrounds and 41% are aged between 56 and 85 years old.

The trial, which is testing people at 150 sites in the US, Germany, Turkey, South Africa, Brazil and Argentina, will collect data on the safety and efficacy of the vaccine for another two years.

SourceBBC

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

EC outlines measures to ensure PWDs vote independently

The Electoral Commission (EC) says it has put in measures to ensure that People With Disabilities (PWDs) cast their...

“More progress, more prosperity and more development in my 2nd term – President Akufo-Addo

“The New Patriotic Party has the blueprint for the development of Ghana, the foundation for that development has been laid in Akufo-Addo’s first term...

Kantamanto GCB Bank fire started from storeroom

Preliminary investigations have established that the wildfire that gutted the Liberty House branch of the GCB Bank at Kantamanto, in Accra, on Saturday, started...

Methodist University awaits accreditation to introduce new programmes

The The Methodist University College Ghana (MUCG) is awaiting approval from the National Acceleration Authority to introduce a couple of new programmes. The programmes are...

2020 Elections: EC extends media accreditation to Monday November 30

The Electoral Commission (EC) has extended media accreditation for the 2020 Presidential and Parliamentary elections to tomorrow (November 30,2020) at 5pm.   A statement from the...

More Articles Like This